AP2002002462A0 - Pharmaceutically active compounds. - Google Patents

Pharmaceutically active compounds.

Info

Publication number
AP2002002462A0
AP2002002462A0 APAP/P/2002/002462A AP2002002462A AP2002002462A0 AP 2002002462 A0 AP2002002462 A0 AP 2002002462A0 AP 2002002462 A AP2002002462 A AP 2002002462A AP 2002002462 A0 AP2002002462 A0 AP 2002002462A0
Authority
AP
ARIPO
Prior art keywords
active compounds
pharmaceutically active
pharmaceutically
polymorph
solvate
Prior art date
Application number
APAP/P/2002/002462A
Inventor
Charlotte Moira Allerton
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP2002002462A0 publication Critical patent/AP2002002462A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

There is provided a general formula I: or pharmaceutically or veterinarily acceptable salt or polymorph and/or solvate thereof, wherein R1 represents H; C(O)C1-C4 alkyl; C(O)aryl; C(O)heteroaryl and which is useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3',5'-monophosphate phosphodiesterase (and in particular cGMP PDE5) is desired.
APAP/P/2002/002462A 2001-03-09 2002-03-07 Pharmaceutically active compounds. AP2002002462A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0105893.2A GB0105893D0 (en) 2001-03-09 2001-03-09 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
AP2002002462A0 true AP2002002462A0 (en) 2002-06-30

Family

ID=9910362

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002462A AP2002002462A0 (en) 2001-03-09 2002-03-07 Pharmaceutically active compounds.

Country Status (8)

Country Link
AP (1) AP2002002462A0 (en)
GB (1) GB0105893D0 (en)
GT (1) GT200200044A (en)
HN (1) HN2002000050A (en)
PA (1) PA8541101A1 (en)
PE (1) PE20021153A1 (en)
TN (1) TNSN02023A1 (en)
WO (1) WO2002072586A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
KR20070091049A (en) 2002-12-13 2007-09-06 워너-램버트 캄파니 엘엘씨 Alpha-2-delta ligand to treat lower urinary tract symptoms
JP2007516949A (en) * 2003-07-16 2007-06-28 ファイザー・インク Treatment of sexual dysfunction
JP2009503020A (en) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of flibanserin in the treatment of obesity
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
DE602007004615D1 (en) 2006-06-30 2010-03-18 Boehringer Ingelheim Pharma FLIBANSERIN FOR THE TREATMENT OF HARNINE INCONTINENCE AND ASSOCIATED DISEASES
BRPI0716439B8 (en) 2006-08-14 2021-05-25 Boehringer Ingelheim Int pharmaceutical delivery systems comprising flibanserin, process for preparation and use thereof
WO2008022932A2 (en) 2006-08-25 2008-02-28 Boehringer Ingelheim International Gmbh Controlled release system and method for manufacturing the same
UY31335A1 (en) 2007-09-12 2009-04-30 VASOMOTOR SYMPTOMS TREATMENT
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK15532000A3 (en) * 1998-04-20 2001-12-03 Pfizer Inc. Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
CZ20021151A3 (en) * 1999-10-11 2003-03-12 Pfizer Inc. 5-(2-substituted-5-heterocyclyl sulfonylpyrid-3-yl)-dihydropyrazolo[4,3-d]-pyrimidin-7-ones functioning as phosphodiesterase inhibitors
CO5271697A1 (en) * 2000-01-12 2003-04-30 Pfizer Prod Inc COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF AFFECTIONS THAT RESPOND TO AN INCREASE OF TESTOSTERONE

Also Published As

Publication number Publication date
GT200200044A (en) 2002-12-02
TNSN02023A1 (en) 2005-12-23
HN2002000050A (en) 2002-09-13
GB0105893D0 (en) 2001-04-25
PA8541101A1 (en) 2003-11-12
PE20021153A1 (en) 2002-12-17
WO2002072586A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
GB0106661D0 (en) Pharmaceutically active compounds
BR0004779A (en) Pharmaceutically active compounds
CA2287552A1 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
MXPA03006310A (en) Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors.
CA2347950A1 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
GB9823103D0 (en) Pharmaceutically active compounds
AP2002002455A0 (en) 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dIhydropyrazolo[4,3-D] pyrimidin-7-ones as phosphodiesterase inhibitors.
CA2322900A1 (en) 2-(hetero)aryl-substituted purin-6-ones as phosphodiesterase inhibitors
MY130319A (en) Pharmaceutically active compounds
WO2002064590A3 (en) Carboline derivatives
HU0102272D0 (en) Compositions and methods for stimulating gastrointestinal motilis
WO2002064591A3 (en) Carboline derivatives
AP2002002462A0 (en) Pharmaceutically active compounds.
CA2413510A1 (en) Condensed pyrazindione derivatives
CA2527496A1 (en) 4-substituted derivatives of pyrazolo [3,4-d] pyrimidine and pyrrolo [2,3-d] pyrimidine and uses thereof
WO2002079203A8 (en) Imidazo-triazine derivatives as pde 5 inhibitors
EP1241170A3 (en) Pyrazolopyrimidine derivatives
DOP2002000354A (en) PHARMACEUTICALLY ACTIVE COMPOUNDS.
UY27197A1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS